AU2003286142A1 - Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis - Google Patents
Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasisInfo
- Publication number
- AU2003286142A1 AU2003286142A1 AU2003286142A AU2003286142A AU2003286142A1 AU 2003286142 A1 AU2003286142 A1 AU 2003286142A1 AU 2003286142 A AU2003286142 A AU 2003286142A AU 2003286142 A AU2003286142 A AU 2003286142A AU 2003286142 A1 AU2003286142 A1 AU 2003286142A1
- Authority
- AU
- Australia
- Prior art keywords
- lallminin
- metastasis
- antibodies
- gamma
- chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42200902P | 2002-10-29 | 2002-10-29 | |
US60/422,009 | 2002-10-29 | ||
PCT/EP2003/012012 WO2004039401A2 (en) | 2002-10-29 | 2003-10-29 | Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003286142A1 true AU2003286142A1 (en) | 2004-05-25 |
Family
ID=32230306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003286142A Abandoned AU2003286142A1 (en) | 2002-10-29 | 2003-10-29 | Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1578444A2 (es) |
JP (1) | JP2006511493A (es) |
AU (1) | AU2003286142A1 (es) |
CA (1) | CA2502088A1 (es) |
MX (1) | MXPA05004126A (es) |
WO (1) | WO2004039401A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007534631A (ja) * | 2003-10-28 | 2007-11-29 | ノボ ノルディスク アクティーゼルスカブ | ラミニン−5γ2結合性ペプチド、その関連組成物およびその使用 |
WO2005052003A2 (en) * | 2003-11-20 | 2005-06-09 | Biostratum, Inc. | Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis |
JP2012530045A (ja) * | 2008-06-18 | 2012-11-29 | カール トゥリッグバソン, | ラミニン−332のドメインに対する抗体 |
US20140045196A1 (en) * | 2012-08-13 | 2014-02-13 | University Of Tokyo | Methods of prognosis and diagnosis of cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6955924B2 (en) * | 1994-10-04 | 2005-10-18 | Biostratum, Inc. | Laminin chains: diagnostic uses |
US5660982A (en) * | 1994-10-04 | 1997-08-26 | Tryggvason; Karl | Laminin chains: diagnostic uses |
WO2002030465A2 (en) * | 2000-10-12 | 2002-04-18 | University Of Rochester | Compositions that inhibit proliferation of cancer cells |
US7256001B2 (en) * | 2001-08-17 | 2007-08-14 | Eisai R&D Management Co., Ltd. | Reagent for determining laminin 5 antigen in biological sample and assay method |
-
2003
- 2003-10-29 CA CA002502088A patent/CA2502088A1/en not_active Abandoned
- 2003-10-29 JP JP2004547600A patent/JP2006511493A/ja active Pending
- 2003-10-29 MX MXPA05004126A patent/MXPA05004126A/es unknown
- 2003-10-29 WO PCT/EP2003/012012 patent/WO2004039401A2/en active Application Filing
- 2003-10-29 AU AU2003286142A patent/AU2003286142A1/en not_active Abandoned
- 2003-10-29 EP EP03776872A patent/EP1578444A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MXPA05004126A (es) | 2005-10-18 |
JP2006511493A (ja) | 2006-04-06 |
WO2004039401A2 (en) | 2004-05-13 |
EP1578444A2 (en) | 2005-09-28 |
WO2004039401A3 (en) | 2004-06-03 |
CA2502088A1 (en) | 2004-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1208472A1 (en) | Antibodies that bind cell-associated ca 125/o722p and methods of use thereof ca125/o772p | |
AU2003217870A1 (en) | Pini-modulating compounds and methods of use thereof | |
AU2003225668A1 (en) | Pin1-modulating compounds and methods of use thereof | |
AU2003225669A1 (en) | Pin1-modulating compounds and methods of use thereof | |
AU2003213673A1 (en) | Pin1-modulating compounds and methods of use thereof | |
AU2003213606A1 (en) | MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE | |
AU2003219987A1 (en) | Electroluminescent materials and methods of manufacture and use | |
IL164021A0 (en) | Antibodies and anti-pharmaceutical compositions containing the same | |
AU2003205913A1 (en) | Materials and methods relating to cancer diagnosis | |
IL165819A0 (en) | Method of producing organic material and use of the same | |
AUPS305702A0 (en) | Superconducting material and method of synthesis | |
AU2003239610A8 (en) | Tiled biochips and the methods of making the same | |
AU2003219093A1 (en) | Anti-hpv-16 e7 antibodies and their use | |
AU2003286142A1 (en) | Use of antibodies to the gamma 2 chain of lallminin 5 to inhibit tumor growth and metastasis | |
AU2003228450A1 (en) | Inhibition of tumor growth via peroxiredoxin 3 | |
AU2003297612A8 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
AU2003276844A8 (en) | Formulations of modified antibodies and methods of making the same | |
AU2003205751A8 (en) | Plant growth modulation by drl1 and other proteins of the elongator complex | |
AU2003297906A1 (en) | Modulation of interleukin 18 expression | |
WO2005042707A9 (en) | Taspasel 1 and methods of use | |
AU2003215725A1 (en) | Materials and methods relating to the treatment of lymphoma | |
AU2003297181A1 (en) | Compositions and methods for inhibiting tumor growth and metastasis | |
AU2003249364A8 (en) | Algal gdp-mannose-3',5'-epimerases and methods of use thereof | |
AU2003228532A8 (en) | Methods of use of the enzymes of mycothiol synthesis | |
AU2003274911A1 (en) | Mrbs as modifiers of the rb pathway and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |